In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA : An Encouraging Milestone to Further Clinical Drug Development
| dc.contributor.author | Ubah, Obinna | |
| dc.contributor.author | Porter, Andrew J | |
| dc.contributor.author | Barelle, Caroline J | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.date.accessioned | 2020-02-04T15:20:01Z | |
| dc.date.available | 2020-02-04T15:20:01Z | |
| dc.date.issued | 2020-02-03 | |
| dc.description | Funding Information: The authors wish to acknowledge the funding support for this work from Scottish Enterprise (SE) (VNAR_001 (2012)), the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/K010905/1), and Innovate UK (102865). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 14 | |
| dc.format.extent | 1506488 | |
| dc.identifier | 155763580 | |
| dc.identifier | 71d480ac-0f2f-4c0f-bfdb-12e960b1d5da | |
| dc.identifier | 32090129 | |
| dc.identifier | 85079741293 | |
| dc.identifier | 000515768700001 | |
| dc.identifier.citation | Ubah, O, Porter, A J & Barelle, C J 2020, 'In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA : An Encouraging Milestone to Further Clinical Drug Development', Journal of Immunology Research, vol. 2020, 7283239, pp. 7283239. https://doi.org/10.1155/2020/7283239 | en |
| dc.identifier.doi | 10.1155/2020/7283239 | |
| dc.identifier.issn | 2314-7156 | |
| dc.identifier.uri | https://hdl.handle.net/2164/13655 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85079741293&partnerID=8YFLogxK | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Immunology Research | en |
| dc.subject | ANTI-ADALIMUMAB ANTIBODIES | en |
| dc.subject | TNF THERAPY | en |
| dc.subject | INTERFERENCE | en |
| dc.subject | MECHANISMS | en |
| dc.subject | INFLIXIMAB | en |
| dc.subject | DISEASES | en |
| dc.subject | R Medicine | en |
| dc.subject | Immunology and Allergy | en |
| dc.subject | Immunology | en |
| dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
| dc.subject | BB/K010905/1 | en |
| dc.subject.lcc | R | en |
| dc.title | In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA : An Encouraging Milestone to Further Clinical Drug Development | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
